Helen Louise Collins - CHIEF MEDICAL OFFICER at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
ELVN on Nasdaq, IMRA on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Helen Louise Collins since 11/25/2024

Holdings reported by Helen Louise Collins for Enliven Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $30.00 Oct 18, 2024 Direct
Stock Option (right to buy) 171K Feb 6, 2025 Direct Common Stock

Transactions reported by Helen Louise Collins for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.